Jeff Yass’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
Other funds holding ZNTL
SFCM
Jeff Yass's ZNTL Position: Q3 2026 in Review
Jeff Yass reduced its Zentalis Pharmaceuticals (ZNTL) stake by 85% in Q3 2026, selling an estimated $741K and leaving 31,451 shares worth $87.1K. The position accounts for ﹤0.01% of the portfolio, ranked #12644.
Jeff Yass first reported a position in ZNTL in Q4 2020 and has held it in 24 quarters since. The position peaked at $3.22M in Q3 2021. 127 funds tracked by Wall St. Rank hold ZNTL as of Q3 2026.
- Jeff Yass held 31,451 shares of Zentalis Pharmaceuticals worth $87.1K as of Q3 2026.
- Jeff Yass sold 183,662 Zentalis Pharmaceuticals shares in Q3 2026, an estimated $741K.
- Zentalis Pharmaceuticals made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #12644 holding.
- Jeff Yass first reported a position in Zentalis Pharmaceuticals in Q4 2020 and has held it in 24 quarters since.
- Jeff Yass's Zentalis Pharmaceuticals position peaked at $3.22M in Q3 2021.
- 127 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.